{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:58Z","timestamp":1791496678448,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijid.2020.05.117","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T02:09:21Z","timestamp":1591063761000},"page":"117-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["DISSEMINATED BACILLUS-CALMETTE-GU\u00c9RIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW"],"prefix":"10.1016","volume":"97","author":[{"given":"Rina Yue Ling","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Wan Bianca","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu Jun","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woei Kang","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh Cheng","family":"Thoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yin","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Fu","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hwei","family":"Sng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah Moy","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya Shekhar","family":"Jamuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin Ying","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Donceras","family":"Nadua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-qian","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Woon-Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.05.117_bib0005","unstructured":"Ministry of Health (Singapore). 2017. Chapter 7: Childhood immunization. Retrieved from: http:\/\/moh.gov.sg\/docs\/librariesprovider5\/disease-updates\/childhood-immunisation-2017d0b895c2b9464bfd9296deb0cf73e709.pdf [Accessed: Aug 15, 2019]."},{"key":"10.1016\/j.ijid.2020.05.117_bib0010","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1016\/j.vaccine.2014.08.032","article-title":"Investigations into an outbreak of suppurative lymphadenitis with BCG vaccines SSI\u00ae in Singapore","volume":"32","author":"Soh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2020.05.117_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.47102\/annals-acadmedsg.V44N8p297","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin and susceptibility to mycobacterial infections - implications on Bacillus Calmette-Gu\u00e9rin vaccinations","volume":"44","author":"Lee","year":"2015","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"10.1016\/j.ijid.2020.05.117_bib0020","doi-asserted-by":"crossref","first-page":"e94485","DOI":"10.1371\/journal.pone.0094485","article-title":"Clinical characteristics and immunogenetics of BCGosis\/BCGitis in Chinese children: a 6 year follow-up study","volume":"9","author":"Ying","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2020.05.117_bib0025","unstructured":"European Society for Immunodeficiencies (ESID) Clinical Working Party Diagnostic Criteria for PID: BCG Diagnostic Criteria. Available from: http:\/\/esid.org\/Working-Parties\/Clinical-Working-Party\/Resources\/Diagnostic-criteria-for-PID2#Q2. Accessed: June 3, 2019."},{"key":"10.1016\/j.ijid.2020.05.117_bib0030","unstructured":"Hopkins RA, Tan EEK, Jamuar SS, et al. Dominant suppressor variant of human I\u03baB\u03b1 leads to loss of adaptive immune function and innate immune activation.[Paper under review]."},{"key":"10.1016\/j.ijid.2020.05.117_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10875-010-9489-z","article-title":"Molecular Diagnosis of Severe Combined Immunodeficiency\u2014Identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 Mutations in a Cohort of Chinese and Southeast Asian Children","volume":"31","author":"Lee","year":"2011","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2020.05.117_bib0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.01302-08","article-title":"Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics","volume":"53","author":"Ritz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.05.117_bib0045","first-page":"3696","article-title":"Disseminated Bacille Calmette-Gu\u00e9rin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome","volume":"20","author":"Bukhari","year":"2016","journal-title":"Eur Rev Med Pharmacol Sc"},{"key":"10.1016\/j.ijid.2020.05.117_bib0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1542\/peds.98.4.774","article-title":"Idiopathic disseminated Bacillus Calmette-Gu\u00e9rin infection: a French national retrospective study","volume":"98","author":"Casanova","year":"1996","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ijid.2020.05.117_bib0055","first-page":"184","article-title":"Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications","volume":"24","author":"Mazzucchelli","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.ijid.2020.05.117_bib0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in SCID patients: complications, risks and vaccination policies","volume":"133","author":"Marciano","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.ijid.2020.05.117_bib0065","article-title":"Newborn screening for severe combined immunodeficiency in Taiwan","volume":"3","author":"Chien","year":"2017","journal-title":"Int J Neonatal Screen"},{"issue":"6","key":"10.1016\/j.ijid.2020.05.117_bib0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jinf.2012.03.012","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) complications associated with primary immunodeficiency diseases","volume":"64","author":"Norouzi","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2020.05.117_bib0075","series-title":"BCG Vaccine SSI: Summary of product characteristics.","author":"Statens Serum Institut","year":"2015"},{"key":"10.1016\/j.ijid.2020.05.117_bib0080","series-title":"Serum Institute of India (SII) BCG Vaccine (Freeze-dried): package insert.","author":"World Health Organization","year":"2014"},{"issue":"8","key":"10.1016\/j.ijid.2020.05.117_bib0085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1469-0691.2011.03551.x","article-title":"The ins and outs of Mycobacterium tuberculosis drug susceptibility testing","volume":"17","author":"Bottger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2020.05.117_bib0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmi.2016.10.022","article-title":"Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives","volume":"23","author":"Schon","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2020.05.117_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5588\/ijtld.16.0619","article-title":"Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis","volume":"21","author":"Rieder","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.05.117_bib0100","first-page":"139","article-title":"A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis","volume":"12","author":"Katiyar","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.ijid.2020.05.117_bib0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/cir406","article-title":"Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province","volume":"53","author":"Jacobson","year":"2011","journal-title":"South Africa. Clin Infect Dis"},{"key":"10.1016\/j.ijid.2020.05.117_bib0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12941-017-0239-4","article-title":"Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes","volume":"16","author":"Xu","year":"2017","journal-title":"Annal Clin Microbiol Antimicrob"},{"issue":"3","key":"10.1016\/j.ijid.2020.05.117_bib0115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/bcp.13846","article-title":"Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India","volume":"85","author":"Aruldhas","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ijid.2020.05.117_bib0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijtb.2015.04.006","article-title":"Blood levels of isoniazid in Indian children with tuberculosis","volume":"62","author":"Rangari","year":"2015","journal-title":"Ind J Tuberculosis"},{"issue":"10","key":"10.1016\/j.ijid.2020.05.117_bib0125","doi-asserted-by":"crossref","first-page":"e0186200","DOI":"10.1371\/journal.pone.0186200","article-title":"Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2020.05.117_bib0130","series-title":"Genotype MTBDTplus.","author":"Hain Lifescience GmBH","year":"2019"},{"issue":"8","key":"10.1016\/j.ijid.2020.05.117_bib0135","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.05.117_bib0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5588\/ijtld.12.0511","article-title":"Can inhA mutation predict ethionamide resistance?","volume":"17","author":"Vadwai","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2020.05.117_bib0145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care"},{"key":"10.1016\/j.ijid.2020.05.117_bib0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: A global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijid.2020.05.117_bib0155","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JCM.00648-11","article-title":"Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates","volume":"49","author":"Kolibab","year":"2011","journal-title":"J Clin Microb"},{"issue":"3","key":"10.1016\/j.ijid.2020.05.117_bib0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00431-004-1599-2","article-title":"Variable outcome of experimental interferon-\u03b3 therapy of disseminated Bacillus Calmette-Gu\u00e9rin infection in two unrelated interleukin-12R\u03b21-deficient Slovakian children","volume":"164","author":"Ulrichs","year":"2005","journal-title":"Eur J Ped"},{"issue":"3","key":"10.1016\/j.ijid.2020.05.117_bib0165","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jinf.2005.07.009","article-title":"Thirteen years of culture-positive M. bovis-BCG infection in an IL12R\u03b21 deficient patient: treatment and outcome","volume":"52","author":"Rosenzweig","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2020.05.117_bib0170","doi-asserted-by":"crossref","first-page":"691956","DOI":"10.1155\/2011\/691956","article-title":"Treatment of disseminated mycobacterial infection with high-dose IFN-\u03b3 in a patient with IL-12R\u03b21 deficiency","volume":"2011","author":"Alangari","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2020.05.117_bib0175","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaip.2014.12.004","article-title":"Successful treatment of disseminated BCG in a patient with severe combined immunodeficiency","volume":"3","author":"Smith","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ijid.2020.05.117_bib0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","author":"Gatlin","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijid.2020.05.117_bib0185","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220304240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220304240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:52:24Z","timestamp":1761119544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220304240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":37,"alternative-id":["S1201971220304240"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.05.117","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DISSEMINATED BACILLUS-CALMETTE-GU\u00c9RIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.05.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}